Efficacy of Dextromethorphan for Cough in Common Cold

Mechanism and Evidence of Efficacy

Dextromethorphan is a non-sedating opiate that acts as a cough suppressant by centrally modulating the cough reflex, with a clear dose-response relationship and maximum cough reflex suppression occurring at 60 mg 1
It has been shown to suppress acute cough in a single meta-analysis, supporting its use in common cold, with the American Thoracic Society implying its efficacy through related research 2, 3

The British Thoracic Society recommends dextromethorphan as the preferred pharmacological option due to its better safety profile compared to other antitussives 4
Dextromethorphan should be used with caution as some combination preparations contain additional ingredients like pain relievers 1

Menthol by inhalation can provide acute but short-lived cough suppression, as noted in studies on cough relief 1
First-generation antihistamines with sedative properties may suppress cough and are particularly useful for nocturnal cough, according to clinical guidelines 1, 4
Codeine and similar substances have no greater efficacy than dextromethorphan but have a much greater adverse side effect profile and are not recommended 1

For adults with bothersome cough from common cold, the British Thoracic Society suggests starting with non-pharmacological approaches like honey and lemon before considering pharmacological options 4
If pharmacological treatment is needed, dextromethorphan is the preferred option, though higher doses (up to 60 mg) may be needed for optimal effect, as indicated by research on dosage efficacy 1
For nighttime cough disrupting sleep, consider first-generation antihistamines with sedative properties, as recommended by clinical guidelines 1, 4
Avoid codeine-containing products as they offer no advantage over dextromethorphan but have more side effects, according to safety profiles 1

Simple home remedies like honey and lemon mixtures are recommended as first-line treatment for benign viral cough and are often as effective as pharmacological treatments, according to the American Thoracic Society 5
Dextromethorphan is the recommended first-line antitussive agent due to its superior safety profile compared to opioid alternatives, as suggested by the American College of Chest Physicians 6
Hypertonic saline solution and erdosteine are recommended on a short-term basis to increase cough clearance in patients with bronchitis, based on guidelines from the American College of Chest Physicians 6, 7
Ipratropium bromide is the only inhaled anticholinergic agent recommended for cough suppression in patients with URI or chronic bronchitis, according to the American College of Chest Physicians 8, 9
Codeine and other central cough suppressants have limited efficacy for cough due to upper respiratory infections and are not recommended, as stated by the American College of Chest Physicians 6, 9
Coughing up blood, prolonged fever, and feeling unwell are symptoms that require medical attention, as indicated by the American Thoracic Society 5